Pharma channel feed

Phar­ma trade group and pa­tient or­ga­ni­za­tion pres­sure Con­gress with TV ad cam­paigns

Last year
Marketing

J&J shut­ters PhI­II tri­al for pul­monary hy­per­ten­sion drug, block­ing its ex­pand­ed use as patent ex­piry looms

Last year
R&D

Q&A: Bay­er on­col­o­gy head Chris­tine Roth talks strat­e­gy un­der new CEO

Last year

FDA ap­proves first gener­ics for Take­da’s Vy­vanse as AD­HD drug short­ages per­sist

Last year
FDA+

iP­SC biotech Shore­line Bio­sciences wins patent in­fringe­ment suit over Fate, White­head In­sti­tute

Last year
Cell/Gene Tx
Law

Cell­tri­on to build a $94M+ fa­cil­i­ty in South Ko­rea — re­port

Last year
Manufacturing

Court agrees with Ab­b­Vie’s method­ol­o­gy for dam­ages in Take­da case

Last year
Law

Janssen looks to turn PhI­II win for Ry­bre­vant in EGFR-mu­tat­ed NSCLC in­to pres­sure on As­traZeneca block­buster

Last year
R&D

How Bio­con Bi­o­log­ics is tak­ing on the US biosim­i­lars mar­ket

Last year
Marketing

Kriya Ther­a­peu­tics buys sci­en­tif­ic ad­vi­sor’s NASH gene ther­a­py com­pa­ny

Last year
Deals

Schott Phar­ma plans Frank­furt Stock Ex­change list­ing by end of year to boost of­fer­ing to in­jectable drug com­pa­nies

Last year
Financing
Manufacturing

FDA ten­ta­tive­ly ap­proves gener­ic ver­sion of pe­di­atric HIV drug un­der PEP­FAR pro­gram

Last year
FDA+

'F­DA is not a physi­cian,' ap­peals court rules in case against agen­cy's iver­mectin mes­sag­ing

Last year
FDA+
Law

Nestlé parts with peanut al­ler­gy treat­ment Pal­forzia

Last year
Deals

No­var­tis sues over IRA ahead of En­tresto price ne­go­ti­a­tions

Last year
Law

Lung can­cer bio­mark­er cam­paign, launched with As­traZeneca, boosts its reach and adds phar­ma sup­port­ers

Last year
Marketing

Mar­ket­ingRx roundup: No­vavax pro­motes vac­cines on Tik­Tok; BIO read­ies for fall pod­cast sea­son

Last year
Marketing

Bay­er ex­pands Keren­dia heart fail­ure pro­gram to 15,000 pa­tients as it plans to start three Phase III tri­als

Last year
R&D

GSK in­vests $270M in­to vac­cine man­u­fac­tur­ing in Bel­gium

Last year
Manufacturing

FDA of­fers clar­i­ty on post-warn­ing let­ter meet­ings in new draft guid­ance

Last year
FDA+

EMA safe­ty com­mit­tee ramps up warn­ing against use of top­i­ra­mate dur­ing preg­nan­cy

Last year
FDA+

Phar­ma and health­care spend­ing ex­pect­ed to help push ad in­dus­try to first-ever $1T to­tal in 2024, study says

Last year
Marketing

Glob­al threat of an­tibi­ot­ic re­sis­tance high­light­ed in new film sup­port­ed by Pfiz­er, MSD, Sh­iono­gi and AMR Ac­tion Fund

Last year
Marketing

Am­gen and Hori­zon can close their $28B deal af­ter re­solv­ing law­suit by the FTC

Last year
Deals
First page Previous page 102103104105106107108 Next page Last page
A service from the Financial Times